SYDNEY, July 31, 2018 (Newswire.com) – Parnell Pharmaceuticals Holdings Ltd. (OTC PINK: PARNF)  (“Parnell” or the “Company”), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions, today announced it has entered into a credit agreement with affiliated entities of New York-headquartered Marathon Asset Management (“Marathon”). Parnell will use →

DURHAM, N.C.–(BUSINESS WIRE)–Jul. 23, 2018– Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, today announced that the $125 million of senior secured convertible notes held by affiliates (the “holders”) →

Cambridge, UK and Indianapolis, US – 2 July 2018: Acacia Pharma Group plc (“Acacia Pharma”, the “Company” or the “Group”), (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea & vomiting treatments for surgical and cancer patients, has secured a credit facility of up to $30 million with Hercules →

May 23, 2018 at 4:05 PM EDT — Non-dilutive financing extends cash reach to over two years — RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–May 23, 2018– TransEnterix, Inc. (NYSE American: TRXC) (the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that →

Agreement Extends Cash Runway into 2019 SAN JOSE, Calif., May 11, 2018 (GLOBE NEWSWIRE) — Restoration Robotics, Inc. (NASDAQ:HAIR), a leader in robotic hair restoration, announced today that it has reached an agreement with Solar Capital Ltd. and the Life Sciences Group at Bridge Bank to secure a debt facility agreement for $20.0 million. The →

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. announced today that it has entered into a $100 million venture debt facility with Hercules Capital, Inc. (NYSE: HTGC), a leader in customizing debt financing for companies in the life sciences and technology-related markets. “Hercules is pleased to enter into this financing partnership with Tricida at this important stage →

ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ: NVCR) announced today that it has entered into a $150 million term loan agreement with BioPharma Credit PLC (LSE: BPCR), an investment fund managed by Pharmakon Advisors, LP, with proceeds used to pay in full Novocure’s existing $100 million term loan debt and fund working capital. The agreement improves →

Financing will fund the commercial launch of Intuity Medical’s POGO® Automatic™ Blood Glucose Monitoring System, the first fully-integrated blood glucose monitor FREMONT, Calif., Jan. 8, 2018 /PRNewswire/ — Intuity Medical, Inc., a privately-held company developing innovative technologies for diabetes management, announced today that it has closed $42.5M in the initial tranche of a $70M total round →

~ MACRILEN is the First and Only FDA-Approved Oral Drug Indicated For the Diagnosis of Adult Growth Hormone Deficiency, a Rare Endocrine Disorder ~ ~ MACRILEN is Strongbridge’s Second Commercial Product; Expands the Company’s Rare Endocrine Disease Portfolio and Complements its Late-Stage Clinical Development Program for RECORLEV™ (levoketoconazole) in Endogenous Cushing’s Syndrome ~ ~ Strongbridge →

FARMINGTON, Conn. and SUNNYVALE, Calif., Dec. 13, 2017 /PRNewswire/ — Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”) (“Company”), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today it has closed a $15 →